Publicacións en colaboración con investigadores/as de Universidade de Coimbra (35)

2024

  1. Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy

    Pharmaceutics, Vol. 16, Núm. 1

  2. Synthesis of Highly Luminescent Silica-Coated Upconversion Nanoparticles from Lanthanide Oxides or Nitrates Using Co-Precipitation and Sol–Gel Methods

    Gels, Vol. 10, Núm. 1

2022

  1. Bromoditerpenes from the Red Seaweed Sphaerococcus coronopifolius as Potential Cytotoxic Agents and Proteasome Inhibitors and Related Mechanisms of Action

    Marine Drugs, Vol. 20, Núm. 10

  2. Disclosing the antitumour potential of the marine bromoditerpene sphaerococcenol A on distinct cancer cellular models

    Biomedicine and Pharmacotherapy, Vol. 149

  3. New Advances in Biomedical Application of Polymeric Micelles

    Pharmaceutics, Vol. 14, Núm. 8

  4. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology

    ACS Nano, Vol. 16, Núm. 7, pp. 9994-10041

2021

  1. Cytotoxic Mechanism of Sphaerodactylomelol, an Uncommon Bromoditerpene Isolated from Sphaerococcus coronopifolius

    Molecules (Basel, Switzerland), Vol. 26, Núm. 5

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies

    Expert Opinion on Drug Delivery

  2. Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies

    Journal of Controlled Release, Vol. 323, pp. 442-462

  3. Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 148, pp. 88-106

  4. Sphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agents

    Biomedicine and Pharmacotherapy, Vol. 128

2019

  1. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors

    Molecular Pharmaceutics, Vol. 16, Núm. 12, pp. 4757-4774

  2. Sustainable Electro-Responsive Semi-Interpenetrating Starch/Ionic Liquid Copolymer Networks for the Controlled Sorption/Release of Biomolecules

    ACS Sustainable Chemistry and Engineering, Vol. 7, Núm. 12, pp. 10516-10532

2018

  1. From marine origin to therapeutics: The antitumor potential of marine algae-derived compounds

    Frontiers in Pharmacology, Vol. 9, Núm. AUG

  2. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers

    Expert Opinion on Drug Delivery, Vol. 15, Núm. 10, pp. 965-982

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Bone critical defect repair with poloxamine-cyclodextrin supramolecular gels

    International Journal of Pharmaceutics, Vol. 495, Núm. 1, pp. 463-473

  2. In situ administration: Simvastatin in bone regeneration

    Simvastatin Delivery: Challenges and Opportunities (Nova Science Publishers, Inc.), pp. 93-119